Enter your login e-mail to the account
Search
Search parameters
Search results
- Endokrinné a metabolické účinky fyzického tréningu pacientov s hypogonadizmom
Mgr. Milan Sedliak, PhD., LitT., Doc. MUDr. Barbara Ukropcová, PhD., prof. MUDr. Juraj Payer, PhD., MPH, FRCP
(4/2018, Review articles ) - NOVÉ TRENDY V PREVENCII ATEROSKLERÓZY
(3/2007, Events ) - Significance of vitamin D in diabetology
prof. MUDr. Juraj Payer, CSc., MUDr. Peter Jackuliak
(5/2012, Review articles ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - Obesity as a cause of cardio-nephro-hepato-metabolic diseases
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(2/2023, Topic of the year ) - THE ENDOCRINE FUNCTION OF ADIPOSE TISSUE
MUDr. Barbara Ukropcová, Mgr. Jozef Ukropec, PhD., prof. MUDr. Iwar Klimeš, DrSc., prof. MUDr. Ivan Tkáč, PhD.
(3/2008, Topic )
- Komplex metabolic changes in children with obesity
MUDr. Zlatko Marinov, MUDr. Dalibor Pastucha, Ph.D., MBA
(2/2012, Review articles ) - Health and psychosocial consequences of obesity in children and adolescents
MUDr. Irena Aldhoon Hainerová, Ph.D., RNDr. Hana Zamrazilová, Ph.D.
(3/2016, Review articles ) - The effectiveness of treatment with recombinant growth hormone in children with chronic kidney disease
prof. MUDr. Ľudmila Podracká, CSc.
(1/2015, Review articles )
- PHARMACOECONOMICS – ITS POSITION IN DRUG POLICY
prof. RNDr. Viliam Foltán, CSc., Mgr. Veronika Dubajová, PharmDr. Tomáš Tesař, PHD, MBA
(1/2008, Review articles ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Treatment of patients with HR+, HER2- PIK3CA-mutated advanced/metastatic breast cancer: results of trial SOLAR-1
MUDr. Andrej Rosík
(2/2021, Review articles ) - Systemic treatment of breast cancer in pregnancy
MUDr. Oľga Szegheőová
(3/2016, Main topic ) - Mechanizmy imunitného systému v boji proti nádorom a príčiny ich zlyhania
Doc. MUDr. Mária Bucová, CSc., MUDr. Kristína Klučková, Prof. MUDr. Milan Buc, DrSc.
(2/2018, Main topic ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - How do we look at CDK4/6 inhibitors in palliative treatment today
MUDr. Miroslava Malejčíková
(2/2022, Main topic ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Principles of hormonal therapy and chemotherapy in the treatment of metastatic HR+, HER2- breast cancer
MUDr. Miroslava Malejčíková
(6/2018, Review articles )
- The most frequent skin and mucous disorders by diabetes mellitus
prof. MUDr. Mária Šimaljaková, PhD.
(1/2018, Review articles )
- Options treatment of acne vulgaris
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(4/2013, Current pharmacotherapy )